Last updated: 2026-09-09 10:37:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
LENSAR, Inc. (LNSR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $8,46, with a market capitalization of $105,41M and a P/E ratio of 6,81. Over the past 52 weeks, its price has ranged from $4,95 to $12,94. This page covers its latest market performance, valuation, price trends and company information.
$105,41M | |
$8,45 | |
$17,31 | |
$1,80 | |
$8,60 | |
-- | |
123,84K | |
6,81 | |
$12,94 | |
$4,95 | |
-- | |
-- |
LENSAR, Inc. (LNSR) is trading at $8,46 in pre-market trading as of 2026-09-09 10:01:00, down 1,65% ($0,14) from the previous close of $8,60
Pre-market trading shows how investors are pricing LNSR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, LENSAR, Inc. (LNSR) moved from $8,30 to $8,46, representing a gain of 1,90% ($0,16).
The stock traded between $8,21 and $8,73 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 94,62 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 43,9%
LNSR is currently trading at $8,46, placing it 43,9% of the way from its 52-week low of $4,95 to its 52-week high of $12,94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 150 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of LENSAR, Inc. (LNSR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.